Clover Health Investments, Corp. (CLOV)
Market Cap | 1.68B |
Revenue (ttm) | 2.12B |
Net Income (ttm) | -91.39M |
Shares Out | 500.29M |
EPS (ttm) | -0.19 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 4,441,661 |
Open | 3.290 |
Previous Close | 3.280 |
Day's Range | 3.230 - 3.360 |
52-Week Range | 0.606 - 4.710 |
Beta | 2.04 |
Analysts | Hold |
Price Target | 4.00 (+19.4%) |
Earnings Date | Nov 6, 2024 |
About CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee. [Read more]
Financial Performance
In 2023, Clover Health Investments's revenue was $2.04 billion, a decrease of -43.11% compared to the previous year's $3.58 billion. Losses were -$213.36 million, -37.17% less than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for CLOV stock is "Hold" and the 12-month stock price forecast is $4.0.
News
Clover Health: Buy The Dip, Reap The Rewards
Clover's 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Clover continues to grow its topline and improve its bottom line performance. Clover's latest star rating upgra...
Hippocratic AI Establishes a Healthcare Advisory Board Comprised of Seven Industry Visionaries and Business Leaders
PALO ALTO, Calif.--(BUSINESS WIRE)-- #GenAI--The board's purpose is to help guide the company on broad industry issues and complements Hippocratic AI's Physician and Nurse Advisory Councils.
Clover Health Investments, Corp. (CLOV) Q3 2024 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer...
Clover Health's Rally: The Payoff Of A Profitable Pivot
Clover Health's pivot to profitability over growth following the divestiture of the non-insurance segment at the end of 2023 has led to significant earnings improvements. The newly launched Counterpar...
Clover Health to Report Third Quarter 2024 Financial Results on November 6
FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after mar...
2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors
Company's affordable, benefit-rich flagship PPO plans now have 4 Star rating Company's affordable, benefit-rich flagship PPO plans now have 4 Star rating
Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025
Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member Experience Overall Star rating performance increase was d...
Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer
Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Hea...
Undercovered Dozen: Clover Health, Quipt, Vital Energy, STMicroelectronics +
The 'Undercovered' Dozen highlights 12 lesser-covered stocks with strong potential, aiming to provide investment ideas and spark community discussion. Dmytro Konovalov takes a look at the impacts of T...
Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations
New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients New Jersey Native Joseph Brand to Lead Operational Efficiency ...
The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest
FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, Counterpart Health, Inc . (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with The Iowa...
Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference
FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to ...
Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success
Clover Health Investments posted its first profitable quarter as a public company and raised its full-year guidance in Q2. Clover Health's star rating increased by 0.5 stars, which could have a positi...
Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Peter Kuipers - CFO Conference Call P...
Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance
Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP l...
Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference
FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to ...
Clover Health to Report Second Quarter 2024 Financial Results on August 5
FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to great he...
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to ...
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year
The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that ra...
The 'Undercovered' Dozen From June 1-6
The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Biotechs CRISPR Therapeutics, Voyager Therapeutics, and Alnylam Pharmaceuticals are covered al...
Clover Health: New Business Model Is A Game Changer
Clover Health is making its AI-powered technology platform, Clover Assistant, available for other Medicare Advantage payors and providers under the brand name Counterpart Assistant. The new offering w...
Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers
FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to b...
Here's why Clover Health stock price spiked after earnings
Clover Health (NASDAQ: CLOV) stock price went parabolic on Wednesday as investors cheered the company's financial results, forward guidance, and share repurchase program. It surged by over 18%, its be...
Clover Health Investments, Corp. (CLOV) Q1 2024 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Terrence Ronan - Interim CFO Conference ...
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access ...